Annals of Vascular Surgery
Volume 21, Issue 2 , Pages 159-162 , March 2007

Medical Benefits of a Peripheral Vascular Screening Program

  • Jeffrey L. Ballard

      Affiliations

    • Vascular Institute, St. Joseph Hospital, Orange, CA, USA
    • Corresponding Author InformationCorrespondence to: Jeffrey L. Ballard, MD, FACS, Department of Surgery, St. Joseph Hospital, 1140 W. La Veta Avenue, Suite 850, Orange, CA 92868, USA
    • ,
  • Renee Mazeroll

      Affiliations

    • Vascular Institute, St. Joseph Hospital, Orange, CA, USA
    • ,
  • Ryan Weitzman

      Affiliations

    • Vascular Institute, St. Joseph Hospital, Orange, CA, USA
    • ,
  • Timothy R.S. Harward

      Affiliations

    • Vascular Institute, St. Joseph Hospital, Orange, CA, USA
    • ,
  • D. Preston Flanigan

      Affiliations

    • Vascular Institute, St. Joseph Hospital, Orange, CA, USA

References 

  1. Rockman CB, Jacobowitz GR, Gagne PJ, et al. Focused screening for occult carotid artery disease: patients with known heart disease are at high risk. J Vasc Surg. 2004;39:44–51
  2. Kurvers HAJM, van der Graaf Y, Blankensteijn JD, Visseren FLJ, Eikelboom BC for the SMART Study Group. Screening for asymptomatic internal carotid artery stenosis and aneurysm of the abdominal aorta: comparing the yield between patients with manifest atherosclerosis and patients with risk factors for atherosclerosis only. J Vasc Surg. 2003;37:1226–1233
  3. Yin D, Carpenter JP. Cost-effectiveness of screening for asymptomatic carotid stenosis. J Vasc Surg. 1998;27:245–255
  4. Kent KC, Zwolak RM, Jaff MR, et al. Screening for abdominal aortic aneurysm: a consensus statement. J Vasc Surg. 2004;39:267–269
  5. Wilmink ABM, Quick CRG, Hubbard SC, Day NE. Effectiveness and cost of screening for abdominal aortic aneurysm: results of a population screening program. J Vasc Surg. 2003;38:72–77
  6. Goessens BMB, Visseren FLJ, Alga A, Banga J, van der Graaf Y on behalf of the SMART Study Group. Screening for asymptomatic cardiovascular disease with noninvasive imaging in patients at high-risk and low-risk according to the European Guidelines on Cardiovascular Disease Prevention: the SMART study. J Vasc Surg. 2006;43:525–532
  7. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness and treatment in primary care. JAMA. 2001;286:1317–1324
  8. Khan NA, Rahim SA, Anand SS, Simel DL, Panju A. Does clinical examination predict lower extremity peripheral arterial disease?. JAMA. 2006;295:536–546
  9. Hankey GJ, Norman PE, Eikelboom JW. Medical treatment of peripheral vascular disease. JAMA. 2006;295:547–553

 Presented at the 24th Annual Meeting of the Southern California Vascular Surgical Society, Temecula, CA, May 5-7, 2006.

PII: S0890-5096(07)00082-9

doi: 10.1016/j.avsg.2006.10.015

Annals of Vascular Surgery
Volume 21, Issue 2 , Pages 159-162 , March 2007

Article Tools